HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Carminia Maria Della Corte Selected Research
Carminia Maria Della Corte Research Topics
Disease
29
Neoplasms (Cancer)
11/2023 - 07/2013
23
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 07/2013
15
Lung Neoplasms (Lung Cancer)
04/2024 - 07/2013
8
Colorectal Neoplasms (Colorectal Cancer)
10/2023 - 11/2014
4
Bites and Stings (Sting)
04/2024 - 01/2019
4
Carcinogenesis
12/2022 - 11/2014
4
COVID-19
01/2022 - 10/2020
3
Malignant Mesothelioma
12/2022 - 04/2018
3
Neoplasm Metastasis (Metastasis)
04/2018 - 01/2018
2
Disease Progression
10/2023 - 01/2023
2
Cardiotoxicity
01/2023 - 06/2021
2
Squamous Cell Carcinoma of Head and Neck
01/2022 - 08/2021
2
Communicable Diseases (Infectious Diseases)
11/2021 - 01/2021
1
Hemangiosarcoma (Angiosarcoma)
01/2024
1
Airway Obstruction (Choking)
01/2023
1
Hypoxia (Hypoxemia)
01/2023
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2023
1
Pathologic Constriction (Stenosis)
01/2023
1
Hemorrhage
01/2023
1
Hypercapnia
01/2023
1
Adenocarcinoma of Lung
11/2022
1
Pneumothorax
01/2022
1
Heart Arrest (Cardiac Arrest)
12/2021
1
Anemia
12/2021
1
Intraoperative Complications
12/2021
1
Wound Infection (Wound Infections)
12/2021
1
Hepatocellular Carcinoma (Hepatoma)
09/2021
1
Neutropenia
05/2021
1
Craniopharyngioma (Craniopharyngiomas)
01/2021
1
Head and Neck Neoplasms (Head and Neck Cancer)
01/2021
1
Mesothelioma
04/2018
1
Neuroblastoma
01/2018
1
Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2018
Drug/Important Bio-Agent (IBA)
10
ErbB Receptors (EGF Receptor)
IBA
01/2023 - 07/2013
7
Biomarkers (Surrogate Marker)
IBA
04/2024 - 01/2019
7
Cetuximab (Erbitux)
FDA Link
01/2023 - 04/2017
6
Tyrosine Kinase Inhibitors
IBA
01/2024 - 07/2013
6
Monoclonal Antibodies
IBA
11/2022 - 04/2017
5
Immune Checkpoint Inhibitors
IBA
03/2022 - 01/2019
5
Metformin (Glucophage)
FDA Link
Generic
01/2017 - 07/2013
4
DNA (Deoxyribonucleic Acid)
IBA
04/2024 - 01/2019
4
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
11/2022 - 01/2016
3
osimertinib
IBA
01/2024 - 04/2017
3
Proteins (Proteins, Gene)
FDA Link
01/2023 - 01/2018
3
Interferons
IBA
01/2023 - 01/2019
3
Cytokines
IBA
11/2022 - 06/2019
3
avelumab
IBA
03/2022 - 01/2020
3
Gefitinib (Iressa)
FDA Link
04/2017 - 07/2013
3
Erlotinib Hydrochloride (CP 358,774)
FDA Link
04/2017 - 01/2015
2
trifluridine tipiracil drug combination
IBA
10/2023 - 01/2023
2
Panitumumab (Vectibix)
FDA Link
10/2023 - 01/2023
2
RNA (Ribonucleic Acid)
IBA
05/2023 - 01/2023
2
pembrolizumab
IBA
01/2023 - 06/2021
2
Nivolumab
IBA
01/2023 - 06/2021
2
Phosphotransferases (Kinase)
IBA
12/2022 - 06/2014
2
Membrane Proteins (Integral Membrane Proteins)
IBA
11/2021 - 01/2021
2
Growth Factor Receptors
IBA
01/2019 - 11/2014
2
Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
IBA
11/2018 - 11/2014
2
Kisspeptins
IBA
04/2018 - 01/2018
2
Metals
IBA
01/2017 - 01/2015
2
Hypoglycemic Agents (Hypoglycemics)
IBA
11/2013 - 07/2013
1
Glucose (Dextrose)
FDA Link
Generic
11/2023
1
Enzymes
IBA
11/2023
1
Biocompatible Materials (Biomaterials)
IBA
05/2023
1
Interferon-gamma (Interferon, gamma)
IBA
01/2023
1
Antiviral Agents (Antivirals)
IBA
01/2023
1
encorafenib
IBA
01/2023
1
tyrosine receptor (receptor, tyrosine)
IBA
12/2022
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
12/2022
1
Immunoglobulin G (IgG)
IBA
03/2022
1
tyramine-deoxysorbitol
IBA
01/2022
1
cupric sulfide (CuS)
IBA
01/2022
1
Angiogenesis Inhibitors
IBA
01/2022
1
Ipilimumab
IBA
06/2021
1
atezolizumab
IBA
06/2021
1
durvalumab
IBA
06/2021
1
cemiplimab
IBA
06/2021
1
dabrafenib
IBA
01/2021
1
trametinib
IBA
01/2021
1
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
01/2020
1
Interleukin-6 (Interleukin 6)
IBA
06/2019
1
EphA2 Receptor
IBA
01/2019
1
ALW-II-41-27
IBA
01/2019
1
Paraffin
IBA
01/2019
1
Formaldehyde (Formol)
FDA Link
01/2019
1
Peptides (Polypeptides)
IBA
04/2018
1
ceritinib
IBA
01/2018
1
Anaplastic Lymphoma Kinase
IBA
01/2018
1
Crizotinib
IBA
01/2018
Therapy/Procedure
20
Therapeutics
11/2023 - 11/2013
13
Immunotherapy
04/2024 - 11/2018
9
Drug Therapy (Chemotherapy)
04/2024 - 11/2013
6
Radiotherapy
05/2023 - 03/2015
1
Combined Modality Therapy
01/2024
1
Airway Management
01/2023
1
Lasers (Laser)
01/2023
1
Precision Medicine
01/2022
1
Heart Massage
12/2021
1
Blood Transfusion (Blood Transfusions)
12/2021
1
Continuity of Patient Care
09/2021